Synapse Biomedical Inc., of Oberlin, OH, is trying to raise $1.2
million to repay debt and prepare to enter the ALS market with its diaphragm
pacing technology. The device uses electrical stimulation to cause the diaphragm to contract, drawing air into the lungs in a manner that mimics natural breathing, and sidesteps many of the complications of mechanical ventilators. The company says that the ALS market is potentially larger than anticipated, and will use funding from this round to prepare itself for sales.
Click here to read more.Share this: